From gene bombs to classroom curriculum
By Svetlana Reiter, Alexander Ershov, and Farida Rustamova,
Meduza
| 04. 14. 2021
Until recently, the Russian authorities showed little interest in genetics. The breakthrough came in 2019, when the government allocated 127 billion rubles ($1.7 billion) to a special seven-year federal program. In fact, as Meduza learned, the Kremlin’s overall spending on projects involving genetics could actually reach 230 billion rubles ($3 billion) in the coming years. Vladimir Putin personally supervises the implementation of these programs, and he’s put his own relatives and closest friends (in particular, his eldest daughter Maria Vorontsova and the cellist Sergey Roldugin) in charge of overseeing the work. Additionally, the oil giant Rosneft acts as the state’s main corporate partner. Meduza explains how the president became infatuated with a field of science that was heresy in the Soviet Union and neglected in the decades after communism’s collapse.
The journal Nature first approached molecular and cell biologist Fyodor Urnov in late 2014, asking him to review new Chinese research on editing human embryos. The experiments horrified the UC Berkeley professor.
“How to formulate this without using profanity… Generally speaking, [the Chinese scientists] promised to use this method to...
Related Articles
By Aisha Down, The Guardian | 11.10.2025
It has been an excellent year for neurotech, if you ignore the people funding it. In August, a tiny brain implant successfully decoded the inner speech of paralysis patients. In October, an eye implant restored sight to patients who had...
By Jessica Hamzelou, MIT Technology Review | 11.07.2025
This week, we heard that Tom Brady had his dog cloned. The former quarterback revealed that his Junie is actually a clone of Lua, a pit bull mix that died in 2023.
Brady’s announcement follows those of celebrities like Paris...
By Heidi Ledford, Nature | 10.31.2025
Late last year, dozens of researchers spanning thousands of miles banded together in a race to save one baby boy’s life. The result was a world first: a cutting-edge gene-editing therapy fashioned for a single person, and produced in...
By Lauran Neergaard, AP News | 11.03.2025
WASHINGTON (AP) — The first clinical trial is getting underway to see if transplanting pig kidneys into people might really save lives.
United Therapeutics, a producer of gene-edited pig kidneys, announced Monday that the study’s initial transplant was performed successfully...